Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZW) Share-based Compensation (2021 - 2025)

Core Scientific (CORZW) has disclosed Share-based Compensation for 5 consecutive years, with $27.9 million as the latest value for Q4 2025.

  • Quarterly Share-based Compensation rose 16.56% to $27.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $98.2 million through Dec 2025, up 89.19% year-over-year, with the annual reading at $98.2 million for FY2025, 89.19% up from the prior year.
  • Share-based Compensation hit $27.9 million in Q4 2025 for Core Scientific, down from $29.9 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $111.0 million in Q2 2022 to a low of -$1.1 million in Q1 2024.
  • Historically, Share-based Compensation has averaged $21.5 million across 5 years, with a median of $16.9 million in 2022.
  • Biggest five-year swings in Share-based Compensation: soared 5096.54% in 2022 and later tumbled 108.64% in 2024.
  • Year by year, Share-based Compensation stood at $7.9 million in 2021, then surged by 106.26% to $16.3 million in 2022, then grew by 6.93% to $17.5 million in 2023, then skyrocketed by 37.13% to $24.0 million in 2024, then increased by 16.56% to $27.9 million in 2025.
  • Business Quant data shows Share-based Compensation for CORZW at $27.9 million in Q4 2025, $29.9 million in Q3 2025, and $24.2 million in Q2 2025.